Vivo Innovation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vivo innovation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vivo Innovation Today - Breaking & Trending Today

Serán Bioscience Announces Investment by Vivo Capital

Serán Bioscience Announces Investment by Vivo Capital
A majority investment by Vivo Capital, a healthcare investment firm headquartered in Silicon Valley, will fund the expansion of Serán s service offering, the doubling of clean room capacity by year-end, and the development and construction a new commercial scale cGMP manufacturing facility by the end of 2022.
News provided by
Share this article
Share this article
BEND, Ore., Jan. 6, 2021 /PRNewswire/ Serán Bioscience today announced that healthcare investment firm Vivo Capital has made a majority investment in Serán alongside Serán s founders who will continue to lead the Company.
Founded in 2016, Serán is a leading contract development and manufacturing organization providing a comprehensive suite of development, analytical and clinical manufacturing services to pharmaceutical and biotechnology companies. Serán s deep experience and expertise in materials science, formulation development, ....

United States , Palo Alto , Williamson Wyatt , Latham Watkins , Dan Smithey , John Melvin , Suzanne Brady , Prnewswire Sera , Mahendra Shah , William Blair , B Vivo Capital Fund , M Vivo Opportunity Fund , Business Development , Vivo Capital , Managing Director , Vivo Capital Fund , Vivo Opportunity Fund , Vivo Innovation , ஒன்றுபட்டது மாநிலங்களில் , பாலோ ஆல்டோ , வில்லியம்சன் வையட் , லாதம் வாட்கின்ஸ் , டான் ஸ்மீத்ெய் , ஜான் மெல்வின் , ஸுஸ்யாந் பிராடி , மகேந்திரா ஷா ,

Provivi® raises $45.5M to expand global launch

Provivi Team
Successfully introducing insect pheromones to control damaging pests, the increased funding will strengthen the capacity for a global roll-out
SANTA MONICA, CA, UNITED STATES, December 22, 2020 /EINPresswire.com/ Provivi, Inc. ( Provivi ), an emerging crop protection company using pheromones to protect large acreage row crops from major damaging insects, is pleased to inform the completion of a $45.5M financing round. Vivo Capital, a Palo Alto based investment fund, led the round. Returning shareholders, including Kairos Ventures, Temasek, Pontifax AgTech, Tybourne Capital, Lanx Capital, and Spruce Capital, also participated in the financing.
The Series C-2 financing is a new milestone in the growth of our company. It builds upon a very successful year where Provivi achieved several product registrations worldwide and launched our first product commercially in Mexico, said Dr. Pedro Coelho, Co-Founder and CEO ....

United States , Santa Monica , Palo Alto , Pedro Coelho , Ganesh Kishore , Pontifax Agtech , Shan Fu , B Vivo Capital Fund , Provivi Team , Provivi Inc , M Vivo Opportunity Fund , Kairos Ventures , Tybourne Capital , Lanx Capital , Spruce Capital , Managing Partner , Vivo Capital , Vivo Capital Fund , Vivo Opportunity Fund , Vivo Innovation , ஒன்றுபட்டது மாநிலங்களில் , சாந்தா மோனிகா , பாலோ ஆல்டோ , பேடரோ கோல்ோ , கணேஷ் கிஷோர் , ஷான் ஃபூ ,